Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_provenance.
- NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_assertion description "[Overexpression of human EGF receptor HER-2 (erbB2) leads to amplified heregulin (HRG) signaling, promoting more aggressive breast cancer that is nonresponsive to estrogen and the antiestrogenic drug tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_provenance.
- NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_assertion evidence source_evidence_literature NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_provenance.
- NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_assertion SIO_000772 14603258 NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_provenance.
- NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_assertion wasDerivedFrom befree-2016 NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_provenance.
- NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_assertion wasGeneratedBy ECO_0000203 NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_provenance.
- befree-2016 importedOn "2016-02-19" NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_provenance.